BioHarvest Sciences Inc. ...

NASDAQ: BHST · Real-Time Price · USD
9.63
0.41 (4.48%)
At close: Aug 15, 2025, 12:05 PM

BioHarvest Sciences Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
27.68M 25.19M 22.43M 19.13M 15.85M 12.67M 10.6M 8.87M 6.96M 5.5M 3.78M 2.91M 2.48M 2.1M 1.64M 1.05M 675.31K
Cost of Revenue
12.16M 11.25M 10.32M 9.29M 8.01M 7.04M 6.59M 6.04M 5.13M 4.28M 2.96M 2.16M 1.73M 1.43M 1.14M 728K 454K
Gross Profit
15.52M 13.94M 12.11M 9.84M 7.84M 5.63M 4.01M 2.84M 1.83M 1.08M 689.53K 613.53K 627.53K 670K 495K 315K 213K
Operating Income
-7.28M -6.99M -7.85M -7.76M -8.86M -9.97M -9.95M -10.92M -10.51M -10.61M -9.74M -9.44M -9.37M -8.97M -10.29M -9.19M -7.65M
Interest Income
1.47M 1.47M 1.47M 1.9M 619K 2.54M 2.54M 2.11M 2.17M 893.78K 662.78K 737K 4.91M 4.4M 4.1M 4.02M -390K
Pretax Income
-8.62M -12.9M -17.19M -16.23M -18.39M -12.56M -8.13M -10.33M -9.86M -11.24M -10.18M -9.3M -5.15M -9.83M -11.17M -9.97M -13.12M
Net Income
-8.66M -12.91M -17.19M -16.23M -18.39M -12.56M -8.13M -10.33M -9.86M -11.24M -10.18M -9.3M -5.15M -9.83M -11.17M -9.97M -13.12M
Selling & General & Admin
17.4M 15.73M 15.36M 13.37M 12.75M 12.07M 10.9M 11.05M 10.03M 9.35M 8.13M 7.5M 7.13M 6.76M 7.5M 6.68M 5.48M
Research & Development
5M 4.8M 4.45M 4.07M 3.79M 3.37M 2.89M 2.55M 2.15M 2.31M 3.67M 3.93M 4.24M 4.12M 2.56M 2.1M 1.65M
Other Expenses
399K 399K 156K 156K 156K 156K 171K 171K 171K 171K 273K 273K 273K 273K 726K 726K 726K
Operating Expenses
22.8M 20.93M 19.96M 17.6M 16.54M 15.44M 13.8M 13.6M 12.35M 11.83M 11.81M 11.44M 11.38M 10.88M 10.78M 9.5M 7.86M
Interest Expense
2.77M 7.35M 7.63M 7.19M 6.97M 1.96M 607K 1.4M 1.39M 1.4M 1.06M 544K 636K 5.2M 5.47M 5.29M 5.43M
Selling & Marketing Expenses
6.7M 9.26M 9.7M 8.08M 7.12M 6.4M 6.09M 5.88M 5.11M 4.3M 4.6M 3.99M 3.45M 2.96M 2.09M 1.35M 866K
Cost & Expenses
15.86M 32.18M 30.28M 26.89M 24.71M 22.64M 20.55M 19.8M 17.48M 16.11M 13.04M 11.88M 11.38M 10.59M 11.92M 10.23M 8.32M
Income Tax Expense
45.66K 7.77K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
17.33M 17.33M 17.34M 16.35M 13.75M 13.42M 13.42M 13.42M 13.31M 13.07M 13.09M 12.99M 12.98M 12.43M 12.41M 12.33M 12.09M
Shares Outstanding (Diluted)
17.33M 17.33M 17.34M 16.35M 13.75M 13.42M 13.42M 13.42M 13.31M 13.07M 13.09M 12.99M 12.98M 12.43M 12.41M 12.33M 12.09M
EPS (Basic)
-0.5 -0.85 -1.22 -1.19 -1.36 -0.94 -0.61 -0.83 -0.97 -1.07 -1 -1 -0.51 -1.05 -0.91 -0.71 -0.98
EPS (Diluted)
-0.5 -0.85 -1.22 -1.19 -1.36 -0.94 -0.61 -0.83 -0.97 -1.07 -1 -1 -0.51 -1.05 -0.91 -0.71 -0.98
EBITDA
-4.33M -4.23M -7.91M -7.5M -10.06M -9.25M -6.64M -8.08M -7.59M -9.04M -8.47M -8.17M -4.07M -4.26M -5.4M -4.42M -7.44M
EBIT
-6.99M -6.7M -9.57M -9.04M -11.42M -10.6M -7.53M -8.93M -8.46M -9.84M -9.13M -8.76M -4.51M -4.63M -5.7M -4.69M -7.7M
Depreciation & Amortization
1.44M 1.24M 1.13M 989.24K 841.24K 837.24K 813.24K 793K 774K 712K 657.53K 579.53K 464.54K 388.98K 316.45K 292.45K 286.45K